SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-017170
Filing Date
2019-11-14
Accepted
2019-11-14 08:01:32
Documents
86
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 890745
2 ex31-1.htm EX-31.1 11734
3 ex31-2.htm EX-31.2 11525
4 ex32-1.htm EX-32.1 7635
5 ex32-2.htm EX-32.2 7626
  Complete submission text file 0001493152-19-017170.txt   4681682

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cdxi-20190930.xml EX-101.INS 728131
7 XBRL SCHEMA FILE cdxi-20190930.xsd EX-101.SCH 65069
8 XBRL CALCULATION FILE cdxi-20190930_cal.xml EX-101.CAL 70603
9 XBRL DEFINITION FILE cdxi-20190930_def.xml EX-101.DEF 260240
10 XBRL LABEL FILE cdxi-20190930_lab.xml EX-101.LAB 408030
11 XBRL PRESENTATION FILE cdxi-20190930_pre.xml EX-101.PRE 365885
Mailing Address 2800 WOODLAWN DRIVE SUITE 129 HONOLULU HI 96822
Business Address 2800 WOODLAWN DRIVE SUITE 129 HONOLULU HI 96822 808-457-1400
CARDAX, INC. (Filer) CIK: 0001544238 (see all company filings)

IRS No.: 454484428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-181719 | Film No.: 191216391
SIC: 2834 Pharmaceutical Preparations